Advertisement

Related Videos

Amit Sanyal, MD: A Clinician’s Perspective

Welcome and Introduction to Vi3C

Charles Schiffer, MD, on Cost-Effective Use of Tyrosine Kinase Inhibitors for Chronic Myelogenous Leukemia

Matthew Seymour, MD: A Clinical Trialist’s Perspective

Opportunities to Optimize Cancer Policies Panel Discussion

Advertisement

Advertisement




Oct
02
Today In Oncology
Sunvozertinib in Platinum-Pretreated NSCLC With EGFR Exon 20 Insertion Mutations
In Extensive-Stage Small Cell Lung Cancer Novel Maintenance Regimen Boosts Overall Survival
Kidney Cancer Cases Expected to Double by 2050
CT-Adapative SBRT for Recurrent Retroperitoneal Sarcomas
Variation in PSA Levels in Annual Testing Among Individuals Without Prostate Cancer Diagnosis
View More 
Advertisement
© 2025 HSP News Service, L.L.C.
Conexiant Oncology Logo